GlassScriptPhysician profile
Brian James Haseloff
NPI 1942314356
$13,845.33
in general payments reported to CMS, 2019-2025
29 companies · $250 in 2025
The $250 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $457 · 2020: $3,097 · 2021: $1,948 · 2022: $5,169 · 2023: $1,335 · 2024: $1,591 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,751 · Travel and Lodging: $424.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,750.88 |
| Travel and Lodging | $424.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $6,891.84 | 2019-2025 | Proclaim, Eterna, Axium |
| Mml US, INC. | $2,821.40 | 2022-2025 | Reactiv8 |
| Biodelivery Sciences International, INC. | $1,205.85 | 2019-2021 | |
| Spinal Simplicity, LLC | $1,121.69 | 2020-2024 | Ha Minuteman G3-R |
| Boston Scientific Corporation | $259.07 | 2019-2021 | |
| Medtronic, INC. | $212.56 | 2021-2025 | Inceptiv, Intellis Adaptivestim |
| Saluda Medical Americas, INC. | $207.22 | 2023 | Evoke Scs |
| Genesys Orthopedics Systems, L.L.C. | $175.56 | 2022 | |
| Spr Therapeutics, INC | $174.16 | 2022-2023 | Sprint Pns System |
| Collegium Pharmaceutical, INC. | $86.45 | 2022-2024 | Xtampza, Belbuca |
| Allergan, INC. | $68.34 | 2020 | |
| Si-Bone, INC. | $64.36 | 2019-2024 | |
| Hydrocision, INC. | $63.39 | 2020-2021 | |
| Vertos Medical, INC. | $60.49 | 2022-2023 | Mild Device Kit |
| Averitas Pharma INC. | $58.00 | 2023 | Qutenza |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Painteq LLC | $53.69 | 2024 | Painteq |
| Medtronic USA, INC. | $52.40 | 2019 | |
| Nevro Corp. | $39.48 | 2019-2024 | Senza |
| Redhill Biopharma INC. | $36.44 | 2020 | |
| Merz Pharmaceuticals, LLC | $27.51 | 2023 | Xeomin |
| Arbor Pharmaceuticals, INC. | $25.15 | 2020-2021 | |
| Nalu Medical, INC. | $23.51 | 2022 | |
| Depuy Synthes Sales INC. | $23.33 | 2024 | Monovisc |
| Avanos Medical | $21.54 | 2024 | Generator |
| Bioventus LLC | $20.66 | 2019 | |
| Merck Sharp & Dohme LLC | $17.67 | 2024 | Gardasil, Gardasil 9, Capvaxive |
| Pacira Therapeutics, INC. | $16.24 | 2019 | |
| Mdd US Operations, LLC | $15.12 | 2022 | |
| Stratus Medical, LLC | $2.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Haseloff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.